- Market Realist•4 hours ago
For fiscal 2017, Alexion Pharmaceuticals (ALXN) expects to Soliris’ sales to be in the range of $3.02 billion–$3.10 billion.
- Market Realist•5 hours ago
For fiscal 2017, Alexion Pharmaceuticals (ALXN) expects to report revenues in the range of $3.4 billion–$3.5 billion.
- Market Realist•7 hours ago
In 2016, Alexion (ALXN) reported revenues of nearly $3.1 billion, which represents a YoY growth of ~18%.
ALXN : Summary for Alexion Pharmaceuticals, Inc. - Yahoo Finance
Alexion Pharmaceuticals, Inc. (ALXN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||128.00 x 600|
|Ask||132.95 x 600|
|Day's Range||130.66 - 132.53|
|52 Week Range||109.12 - 162.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||75.11|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|